drugset / Trial / NCT01172379
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With "Wearing Off" Motor Fluctuations and "On" Period Dyskinesias
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the safety, tolerability and efficacy of E2007 in Parkinson's Disease patients who have "wearing off" motor fluctuations and "on" period dyskenisias.
Timeline
- Start
- 2004-05
- Primary completion
- 2005-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Perampanel | Small molecule | 0.5 mg | — |
| Subject | Perampanel | Small molecule | 1 mg | — |
| Subject | Perampanel | Small molecule | 2 mg | — |